 NEW YORK, Oct. 4, 2021 PRNewswire -- BrainStorm Cell Therapeutics Inc. NASDAQ: BCLI, a leading developer of cellular therapies for neurodegenerative diseases, announced today that Stacy Lindborg, Ph.D., Executive Vice President and Head of Global Clinical Research, will deliver a presentation at the 2021 Cell Gene Meeting on the Mesa, being held as a hybrid conference October 12-14, and October 19-20, 2021. 